Gastro Esophageal Junction Cancer Recruiting Phase 2 Trials for Trastuzumab (DB00072)

Back to Gastro Esophageal Junction Cancer

Also known as: Gastroesophageal-junction Cancer / Gastroesophageal Junction Cancer / Gastro-oesophageal Junction Cancer / Gastro-esophageal Junction Cancer / Gastrooesophageal junction cancer / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Carcinoma of esophagus (disorder) / Carcinoma of esophagus / Oesophageal carcinoma NOS / Oesophageal carcinoma / Esophageal carcinoma NOS / Esophageal carcinoma / Primary malignant neoplasm of esophagus (disorder)

IndicationStatusPhase
DBCOND0106887 (Gastro Esophageal Junction Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04510285A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative ResectionTreatment